Why USG (USG) Stock Is Advancing Today

NEW YORK (TheStreet) -- Shares of USG Corp.  (USG) are up 2.35% to $29.65 following a Barron's article over the weekend which said that "it typically takes a few months before the sound of shovels hitting dirt at a new housing project leads to pay dirt for [the] wallboard maker. The delay, however, bodes well for USG investors, who can expect to see the recent upswing in housing starts reflected in the company's results shortly."

USG, based in Chicago, also makes ceiling tiles and other building products, and "has climbed out of a deep hole since the housing market crashed. But its results have been depressed, as builders remain reticent to ramp up construction. That's created an opportunity," Barron's said.

Must Read: 50 Stocks Hedge Funds Love

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TheStreet Ratings team rates USG CORP as a Hold with a ratings score of C. TheStreet Ratings Team has this to say about their recommendation:

"We rate USG CORP (USG) a HOLD. The primary factors that have impacted our rating are mixed some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity and reasonable valuation levels. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk and poor profit margins."

Highlights from the analysis by TheStreet Ratings Team goes as follows:

  • USG's revenue growth has slightly outpaced the industry average of 2.4%. Since the same quarter one year prior, revenues slightly increased by 3.5%. Growth in the company's revenue appears to have helped boost the earnings per share.
  • Compared to where it was a year ago today, the stock is now trading at a higher level, reflecting both the market's overall trend during that period and the fact that the company's earnings growth has been robust. Despite the fact that it has already risen in the past year, there is currently no conclusive evidence that warrants the purchase or sale of this stock.
  • The gross profit margin for USG CORP is rather low; currently it is at 21.31%. Regardless of USG's low profit margin, it has managed to increase from the same period last year. Despite the mixed results of the gross profit margin, USG's net profit margin of 6.01% compares favorably to the industry average.
  • The debt-to-equity ratio is very high at 2.79 and currently higher than the industry average, implying increased risk associated with the management of debt levels within the company. Even though the debt-to-equity ratio is weak, USG's quick ratio is somewhat strong at 1.46, demonstrating the ability to handle short-term liquidity needs.
  • You can view the full analysis from the report here: USG Ratings Report
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he and Stephanie Link think could be potentially HUGE winners. Click here to see the holdings for FREE

If you liked this article you might like

Hot Housing Data Is Powering These Stocks to New 52-Week Highs

Hot Housing Data Is Powering These Stocks to New 52-Week Highs

Activision Blizzard, Xilinx, Priceline Group: 'Mad Money' Lightning Round

Activision Blizzard, Xilinx, Priceline Group: 'Mad Money' Lightning Round

Buy on Weakness: Cramer's 'Mad Money' Recap (Thursday 10/19/17)

Buy on Weakness: Cramer's 'Mad Money' Recap (Thursday 10/19/17)

A Stampede of Buying: Cramer's 'Mad Money' Recap (Monday 9/11/17)

A Stampede of Buying: Cramer's 'Mad Money' Recap (Monday 9/11/17)

Allergan, USG Corp, Arena Pharmaceuticals: 'Mad Money' Lightning Round

Allergan, USG Corp, Arena Pharmaceuticals: 'Mad Money' Lightning Round